Sepsis evaluations in hospitalized infants with bronchiolitis

Pediatr Infect Dis J. 1998 Mar;17(3):231-6. doi: 10.1097/00006454-199803000-00011.

Abstract

Objectives: To define variation in the decision to perform a sepsis evaluation in hospitalized infants with bronchiolitis, to define predictors of the decision and to measure the clinical and cost outcomes.

Methods: Retrospective chart review of all nonintensive care unit infants < or = 60 days with any discharge diagnosis of bronchiolitis (n = 282 from 1993 to 1995 in a 232-bed pediatric hospital. Process variables included temperature at sepsis work-up or Tmax if no sepsis workup. Outcome variables were charges, length of stay, sepsis workup and serious bacterial infection.

Results: There was no difference in mean temperature between groups with or without sepsis evaluation (38.1 degrees C, P = 0.75). Of 282 infants 140 had a sepsis workup; 5 (1.8%) had serious bacterial infection. Infants with sepsis workup had an average total charge of $4507 and length of stay of 3.4 days compared with $2998 and 2.8 days for those without (P = 0.0001 and P = 0.002, respectively). A multivariate logistic regression model was constructed with sepsis workup as the dichotomous dependent variable. Significant (P < or = 0.05) predictor variables with a positive coefficient were: higher bronchiolitis score and normal chest roentgenogram. Significant variables with a negative coefficient were: admission diagnosis of bronchiolitis, chest roentgenogram typical for bronchiolitis and age > 28 days.

Conclusions: Temperature was not a predictor of sepsis evaluation. Infants with respiratory distress and normal chest roentgenogram were more likely to receive sepsis evaluations; those with recognized typical bronchiolitis and those > 28 days of age were less likely. Risk of serious bacterial infection is low; the costs of a sepsis evaluation outweigh the benefits in infants with obvious bronchiolitis.

MeSH terms

  • Bronchiolitis / complications*
  • Bronchiolitis / economics
  • Cost-Benefit Analysis
  • Cross Infection / economics
  • Cross Infection / prevention & control*
  • Decision Support Techniques*
  • Fever
  • Hospital Charges
  • Humans
  • Infant
  • Length of Stay / economics
  • Logistic Models
  • Outcome Assessment, Health Care*
  • Retrospective Studies
  • Sepsis / economics
  • Sepsis / prevention & control*